Atossa Therapeutics Inc (NASDAQ:ATOS)

Delayed Data
As of Apr 19
 -0.12 / -7.36%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 6.38, with a high estimate of 7.75 and a low estimate of 5.00. The median estimate represents a +322.19% increase from the last price of 1.51.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.32%
Growthannually 90.36%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.